Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2025) 110 P48 | DOI: 10.1530/endoabs.110.P48

1Sapienza University of Rome, Department of Internal Medicine and Medical Specialties, Rome, Italy; 2University of Oxford, Churchill Hospital, Oxford, Oxford Centre for Diabetes, Endocrinology and Metabolism, NIHR Oxford Biomedical Research Centre, Oxford, UK


JOINT3709

Background: Emerging evidence suggests that mild autonomous cortisol secretion (MACS) might be directly associated with increased cardiac mass and diastolic dysfunction compared to non-functioning adrenal incidentalomas (NFAI). Nevertheless, the reversibility of these alterations following appropriate treatment has never been investigated. This study evaluated cardiac morphology in patients with adrenal incidentalomas over a 5-year follow-up period, comparing the effects of active surveillance to adrenalectomy in patients with MACS.

Methods: This prospective longitudinal case–control study included 60 patients with adrenal incidentalomas. After stratification based on cortisol levels post-dexamethasone suppression test, 34 patients with MACS and 26 with NFAI were evaluated for clinical, biochemical, and echocardiographic parameters at baseline and after 1 and/or 5 years of follow-up. Patients with MACS were managed either with active surveillance (AS, n=23) or unilateral adrenalectomy (ADRX, n=11), according to current recommendations.

Results: At baseline, patients with MACS showed higher left ventricular mass index (LVMi, P=0.021), interventricular septal (IVS) (P=0.007), and posterior wall (PW) thickness (P=0.004) compared to NFAI, along with higher prevalence of diastolic dysfunction and left ventricular hypertrophy (P=0.050 and P=0.013). Patients undergoing ADRX presented with larger adrenal mass diameters, higher prevalence of arterial hypertension, and lower ACTH levels (P<0.001 for all). After 1 year, the ADRX group showed a significant reduction in LVMi (P=0.031), IVS (P=0.042), and PW thickness (P=0.037), followed by a progressive increase to baseline values at the 5-year timepoint. The AS group showed overall long-term stability in cardiac parameters, while the NFAI group showed a significant, progressive increase of cardiac indexes through the 5-year follow-up. Accordingly, the ADRX showed a significantly higher decrease in LVMi and PW thickness compared to the other two groups at the 1-year follow-up, even adjusting for sex and age (P<0.001, P=0.003). No significant inter-group differences were detected at the 5-year follow-up. In patients with MACS, linear regression analysis showed that unilateral adrenalectomy was the element most strongly associated with the 1-year improvement in LVMi (R2=0.423, P=0.017) and PW thickness (R2=0.422, P=0.023). The overall progression of the main cardiometabolic comorbidities remained comparable among the three groups.

Conclusions: Patients with MACS exhibit early cardiac remodelling compared to NFAI, independent of conventional risk factors. Unilateral adrenalectomy induced short-term improvement in cardiac parameters, which was not maintained on the long-term. Active surveillance in MACS resulted in long-term cardiac stability, likely reflecting the more intensive cardiovascular monitoring compared to NFAI, and underscoring the importance of cardiovascular monitoring to pursue individualized treatment strategies.

Volume 110

Joint Congress of the European Society for Paediatric Endocrinology (ESPE) and the European Society of Endocrinology (ESE) 2025: Connecting Endocrinology Across the Life Course

European Society of Endocrinology 
European Society for Paediatric Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches